Last reviewed · How we verify

NCT04207073

Assessment of Two Point Discrimination

Completed NA Last updated 17 November 2021
What this trial tests

NA trial testing Mobilization of median nerve in Assessment, Self in 120 participants. Completed in 26 June 2021.

Timeline
23 December 2019
Primary endpoint
24 April 2021
26 June 2021

Quick facts

Lead sponsorMedipol University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposehealth services research
Enrollment120
Start date23 December 2019
Primary completion24 April 2021
Estimated completion26 June 2021
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Medipol University

Who can join

Adults 20 to 25, any sex, with Assessment, Self. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

When the studies in the literature are examined, no study has been reached to examine whether median nerve mobilization causes changes in two-point discriminatory values in healthy individuals. This study aimed to investigate the effect of median nerve mobilization exercise on two-point discrimination in healthy adult male and female participants. Secondly, it was aimed to determine the role of variables such as gender, age, BMI (weight in kilograms, height in meters and weight and height will be combined to report BMI in kg/m\^2), smoking, dominant extremity and physical activity level in 2-point discrimination.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Assessment, Self

Currently open trials in the same condition.

Other Medipol University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04207073.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing